Kamada Shares Slide After It Raises $51.6 Million in U.S. IPO

The biopharmaceutical company share prices fall on the Tel Aviv Stock Exchange on Sunday.

Jun 03, 2013 6:09 AM

Kamada, a biopharmaceutical company whose unique protein purification technology is used to develop treatments for lung and other diseases, saw its Tel Aviv Stock Exchange share price fall yesterday after it...

Comments

Sort comments by

Kamada Shares Slide After It Raises $51.6 Million in U.S. IPO

Comments

ICYMI

The Grisly Hit-job on Khashoggi Is a Disaster for Israel

Why Nobel Prize Winner Daniel Kahneman Gave Up on Happiness

The Mossad Ran a Fake Diving Resort for Tourists in Sudan. This Is the Incredible Story Behind It

The Israel You Know Just Ended. You Can Thank Netanyahu

Russia Fabricated the Radar Image: Israeli Version of Spyplane Downing

General's Final Confession Links 1956 Massacre to Israel's Secret Plan to Expel Arabs

Evolution's Holy Grail: 90,000-year-old Hybrid Teenager Stuns Science World

A Golden Age for the Mossad: More Targets, More Ops, More Money

Netanyahu Reignites the Leftist’s Dilemma

Analysis With Russia's S-300 in Syria, Israel Will Have to Think Twice About the Next Strike

Downing of Russian Plane: Israel Fears Putin Will Clip Its Wings in Syria

Donald Trump Thinks the Jews Aren't Grateful Enough

Syria Strike: Putin Forgives, but What About Iran?

Israel’s Isolation as an Adoring Trumpland

In Ukraine, Manafort's Israel Link Met With Silence

Israel Gives China Keys to Its Largest Port. The U.S. Navy May Abandon Israel

How Kushner Played Matchmaker Between Israel and Saudi Arabia

Iran, Russia Prepare to Battle Each Other Over Control of Post-war Syria

How the Saudis Made Canada the Loneliest Country in the World

This Was Bibi's Best Year. Next Year Could Be His Worst

Comments

Thank you!

ICYMI